Fulcrum Therapeutics News

Fulcrum Therapeutics | 8-K: Current report

May 13 19:09

Fulcrum Therapeutics | DEF 14A: Definitive information statements

Apr 20 04:13

Fulcrum Therapeutics | DEFA14A: Others

Apr 20 04:10

Fulcrum Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 28 06:22

Fulcrum Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Feb 28 06:18

Fulcrum Therapeutics | 8-K: Current report

Feb 27 20:05

Fulcrum Therapeutics | 8-K: Current report

Nov 7, 2023 20:02

Fulcrum Therapeutics | 8-K: Current report

Oct 3, 2023 04:01

Fulcrum Therapeutics | 8-K: Current report

Aug 22, 2023 19:01

Fulcrum Therapeutics | 8-K: Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2023

Aug 3, 2023 19:05

Fulcrum Therapeutics | 8-K: Current report

Jul 11, 2023 05:06

Fulcrum Therapeutics | 8-K: Current report

Jun 10, 2023 04:05

Fulcrum Therapeutics | 8-K: Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for the First Quarter 2023

May 15, 2023 19:06

Fulcrum Therapeutics | DEFA14A: Others

Apr 29, 2023 04:10

Fulcrum Therapeutics | DEF 14A: Definitive proxy statements

Apr 29, 2023 04:02

Fulcrum Therapeutics | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition

Apr 19, 2023 04:05

Fulcrum Therapeutics | 8-K: Current report

Apr 5, 2023 20:13

Fulcrum Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 9, 2023 21:27

Fulcrum Therapeutics | 8-K: Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for the Fourth Quarter and Full Year 2022

Mar 9, 2023 20:14

Fulcrum Therapeutics | 8-K: Current report

Jan 19, 2023 06:12